Wednesday, November 11, 2026

AI Infrastructure Stocks Surge 166-315% While Software Sector Faces Broad Selloff

SanDisk gained 315.3% and Western Digital surged 166.1% as AI infrastructure providers diverge from software stocks in a market-wide tech selloff. Micron Technology posted record Q1 2026 revenues with margin expansion, while Nebius announced $16-20B capex plans with 60% self-funded from operations.

AI Infrastructure Stocks Surge 166-315% While Software Sector Faces Broad Selloff
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Storage and semiconductor stocks rallied sharply in early 2026 despite widespread AI and tech sector declines. SanDisk stock jumped 315.3% while Western Digital shares climbed 166.1%, marking a clear separation between infrastructure providers and software companies.

Micron Technology reported record revenues and expanding margins in its fiscal Q1 2026 earnings. The memory chip maker's performance reflects sustained demand for data center infrastructure as AI model training and inference workloads intensify.

Two companies disclosed a combined $400 billion in capital expenditure commitments for AI infrastructure buildout. Nebius separately projected $16-20 billion in capex over the coming period, with 60% funded from operational cash flow rather than external financing.

The stock performance gap signals investor repositioning toward companies selling physical infrastructure—chips, storage, data centers—and away from AI application developers. Hardware providers generate immediate revenue from infrastructure deployment, while software companies face longer monetization timelines and market uncertainty.

Analysts characterize the broader tech selloff as indiscriminate, hitting profitable and speculative companies alike. The infrastructure rally suggests investors distinguish between companies building AI systems and those attempting to profit from AI-powered products.

Storage companies benefit from dual demand drivers: expanded data center capacity and higher storage density requirements for large language models. Training runs for frontier AI models now require petabytes of high-speed storage, creating sustained order backlogs.

The valuation split creates a bifurcated market where price-to-earnings ratios and revenue multiples compress for software firms while expanding for hardware makers. Infrastructure companies trade on tangible deployment metrics—chip shipments, storage capacity sold, data center square footage—rather than speculative user adoption curves.

Capital flows into infrastructure reflect confidence in near-term AI spending regardless of application-layer success. Tech giants and cloud providers committed to multi-year buildouts must acquire chips and storage systems before launching services, guaranteeing hardware revenue even if consumer AI products underperform.

The trend positions semiconductor and storage firms as lower-risk AI plays compared to software developers betting on unproven business models.

In this story

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com